Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106).

Authors

null

Akira Fukutomi

Divison of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Akira Fukutomi , Junki Mizusawa , Hiroshi Katayama , Satoaki Nakamura , Yoshinori Ito , Nobuyoshi Hiraoka , Tatsuya Ioka , Makoto Ueno , Masafumi Ikeda , Kazuya Sugimori , Kyoko Shimizu , Takuji Okusaka , Masato Ozaka , Hiroaki Yanagimoto , Shoji Nakamori , Takeshi Azuma , Ayumu Hosokawa , Naohiro Sata , Tetsuya Mine , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

000006811

Citation

J Clin Oncol 33, 2015 (suppl; abstr 4116)

DOI

10.1200/jco.2015.33.15_suppl.4116

Abstract #

4116

Poster Bd #

227

Abstract Disclosures